LGALS8 Human

Galectin-8 Human Recombinant
Cat. No.
BT11393
Source
Escherichia Coli.
Synonyms
Galectin-8, Gal-8, Po66 carbohydrate-binding protein, Po66-CBP, Prostate carcinoma tumor antigen 1, PCTA-1, LGALS8.
Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Purity
Greater than 95.0% as determined by:
(a) Analysis by RP-HPLC.
(b) Analysis by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

Galectin-8 Human Recombinant produced in E.Coli is a single, non-glycosylated, Polypeptide chain containing 317 amino acids and having a molecular mass of 35.8kDa.
The LGALS8 is purified by proprietary chromatographic techniques.

Product Specs

Introduction
Galectins are a family of animal lectins that bind to beta-galactosides. There are at least 14 known members of this family. All galectins share a conserved carbohydrate recognition domain (CRD). They are primarily synthesized in the cytoplasm and lack a typical signal peptide for secretion. However, they can be secreted through unconventional pathways or transported to the nucleus. Galectins play a role in regulating interactions between cells and between cells and the extracellular matrix. Galectin-8, a tandem-repeat-type galectin, comprises two CRDs connected by a linker peptide. Its expression is elevated in lung carcinomas, various prostate cancer types, and other tumor cells. Galectin-8 binds to specific cell surface integrins, thereby influencing integrin-ECM interactions. When immobilized, it promotes cell adhesion by binding and clustering integrin receptors on the cell surface. Conversely, as a soluble ligand, it can inhibit cell adhesion.
Description
Recombinant Human Galectin-8, expressed in E. coli, is a single, non-glycosylated polypeptide chain containing 317 amino acids. It has a molecular weight of 35.8 kDa. The protein is purified using proprietary chromatographic techniques.
Physical Appearance
Sterile, white lyophilized powder.
Formulation
LGALS8 was lyophilized from a 1 mg/ml solution in 20 mM PBS at pH 7.4.
Solubility
Reconstitute the lyophilized Galectin-8 in sterile 18 MΩ cm H2O to a concentration of at least 100 µg/ml. The reconstituted solution can be further diluted in other aqueous solutions.
Stability
Lyophilized LGALS8 is stable at room temperature for up to 3 weeks. However, it is recommended to store the lyophilized protein desiccated at -18°C or below. After reconstitution, store Galectin-8 at 4°C for 2-7 days. For long-term storage, freeze the solution at -18°C or below. Avoid repeated freeze-thaw cycles.
Purity
Greater than 95% as determined by: (a) RP-HPLC analysis (b) SDS-PAGE analysis.
Biological Activity
The ED50 of Galectin-8, as measured by its ability to agglutinate human red blood cells, is 0.8-4 µg/ml.
Synonyms
Galectin-8, Gal-8, Po66 carbohydrate-binding protein, Po66-CBP, Prostate carcinoma tumor antigen 1, PCTA-1, LGALS8.
Source
Escherichia Coli.
Amino Acid Sequence
The sequence of the first five N-terminal amino acids was determined and was found to be Met-Met-Leu-Ser-Leu.

Product Science Overview

Introduction

Galectin-8, also known as prostate carcinoma tumor antigen 1 (PCTA1), is a member of the galectin family of proteins. Galectins are a group of β-galactoside-binding proteins that play crucial roles in various biological processes, including cell adhesion, migration, proliferation, and apoptosis. Galectin-8 is a tandem-repeat type galectin, meaning it contains two carbohydrate recognition domains (CRDs) connected by a linker peptide .

Structure and Expression

Galectin-8 was initially cloned from a rat liver cDNA library and is composed of 316 amino acids with a molecular weight of approximately 35 kDa . The protein is highly expressed in various tissues, including lung carcinomas, certain forms of prostate carcinomas, and other tumor cells . It is also expressed in the villous and extravillous trophoblast cells of the human placenta, indicating its role in pregnancy establishment .

Biological Functions

Galectin-8 is involved in a wide range of biological functions:

  • Cell Adhesion and Migration: Galectin-8 promotes cell adhesion and migration by interacting with β-galactosides on cell surface glycoproteins and the extracellular matrix . This function is particularly important in processes such as tissue regeneration and cancer metastasis.
  • Proliferation and Apoptosis: Galectin-8 modulates cell proliferation and apoptosis, contributing to its role in cancer progression .
  • Angiogenesis: Galectin-8 plays a key role in angiogenesis, the formation of new blood vessels, which is crucial for tumor growth and wound healing .
  • Trophoblast Invasion: In the context of pregnancy, galectin-8 stimulates the adhesion, migration, and invasion of extravillous trophoblast cells, which are essential for the proper implantation and development of the placenta .
Recombinant Human Galectin-8

Recombinant human galectin-8 is produced using E. coli expression systems. The recombinant protein is typically purified to a high degree of purity (>97%) and is used in various research applications . It is available in both carrier-free and carrier-containing formulations, with the carrier protein (usually bovine serum albumin) enhancing protein stability and shelf-life .

Applications in Research

Recombinant human galectin-8 is widely used in research to study its various biological functions. It is used in cell-based assays to investigate its effects on cell adhesion, migration, proliferation, and apoptosis. Additionally, it is used in studies related to cancer, tissue regeneration, and pregnancy .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.